As another disease model, Kim et al (60) reported that induction of Atf3 plays a pivotal role in disease progression in the livers of Zucker diabetic fatty (ZDF) rats, a model of type 2 diabetes exhibiting hepatic steatosis, and patients with nonalcoholic fatty liver disease (60). This evidence concerns the gene ATF3 and metabolic dysfunction-associated steatotic liver disease.